List and price list of anti-cancer drugs in 2018
10, Velcade ® (boron for zc meters)
Seller: Johnson & Johnson and takeda pharmaceutical
Drug type: proteasome inhibitor
Indications: multiple myeloma, nested cell lymphoma
9, Ibrance ® (Mr Bossi)
Seller: Pfizer
Drug type: kinase inhibitor
Indications: treatment for women with advanced or metastatic breast cancer who have advanced hormone receptor positive (HR+) or human epidermal growth factor receptor negative (HER2-) after endocrine therapy.
8, Keytruda ® (palmer mother single resistance)
Seller: MSD
Drug type: pd-1 antibody
Indications: melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, Hodgkin’s lymphoma, bladder cancer, high microsatellite instability cancer, gastric cancer.
7, Imbruvica ® (according to the lu for)
Seller: Johnson & Johnson and abbev
Drug type: kinase inhibitor
Indications: lymphoma of the sheath cells (MCL) has received at least one prior treatment; Chronic lymphocytic leukemia (CLL) has received at least one prior treatment; Chronic lymphocytic leukemia has a loss of 17p.
6. Opdivo (navudane)
Seller: BMS
Drug type: pd-1 antibody
Indications: melanoma, metastatic NSCLC, advanced renal cell carcinoma, classic Hodgkin’s lymphoma, head and neck squamous cell carcinoma, bladder cancer, colorectal cancer and hepatocellular carcinoma.
5. Neulasta/Peglasta and Neupogen/Gran
Seller: amgen and Kyowa Hakko Kirin2
Indications: for the patients with myeloid malignancies, in patients with acute myelogenous leukemia (AML) induction or consolidation chemotherapy, the drug can reduce neutrophil recovery and heating duration, reduce chemotherapy neutropenia after bone marrow transplantation and the clinical sequelae associated neutropenia duration, etc.
4. Avastin (bevacizumab)
Seller: roche (genentech)
Drug type: recombinant humanized monoclonal antibody
Indications: metastatic colorectal cancer, non-squamous cell lung cancer, glioblastoma, metastatic renal cell carcinoma, cervical cancer, recurrent ovarian epithelial carcinoma, fallopian tube carcinoma or primary peritoneal carcinoma.
3. Herceptin (trastuzumab)
Seller: roche
Drug type: HER2/neu receptor antagonist
Indications: metastatic breast cancer with HER2 overexpression, metastatic gastric adenocarcinoma with HER2 overexpression, or gastric esophageal junction adenocarcinoma.
2, Rituxan ® (Rituxan, MabThera)
Sales: Genentech and Biogen
Drug type: CD20 targeted lysosomes
Indications: non-hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis (RA), wegener granuloma (WG), microscopically multivasculitis (MPA).
1, the Revlimid ® (drug lenalidomide)
Seller: Celgene
Drug type: thalidomide analogue
Indications: multiple myeloma, recurrent and refractory lymphoma of the nested cells.
